No headlines found.
PRNewswire (Mon, 5-Oct 7:08 AM ET)
MiniMed appoints Sheila Denton as General Counsel & Corporate Secretary
PRNewswire (Mon, 28-Sep 9:03 AM ET)
Medtronic Launches Exchange Offer to Complete Separation of MiniMed Group, Inc.
PRNewswire (Mon, 14-Sep 7:30 AM ET)
PRNewswire (Mon, 14-Sep 7:30 AM ET)
MiniMed Delivers Strong Start to Fiscal Year 2027 with U.S. Growth Acceleration
PRNewswire (Tue, 1-Sep 6:46 AM ET)
MiniMed to Participate in Upcoming Investor Conferences
PRNewswire (Tue, 25-Aug 9:03 AM ET)
MiniMed's Smallest App-Controlled Insulin Pump Now Shipping with the World's Smallest Sensor
PRNewswire (Mon, 17-Aug 9:04 AM ET)
MiniMed Flex Now Available to Medicare and Medicare Advantage Beneficiaries
PRNewswire (Wed, 22-Jul 9:05 AM ET)
MiniMed to Announce Its Fiscal Year 2027 First Quarter Financial Results
PRNewswire (Mon, 20-Jul 7:00 AM ET)
While MiniMed recently became an independent company again, it began in the 1980s as an upstart pioneer in developing and commercializing insulin pump therapy. Medtronic acquired MiniMed in 2001 and then spun it out in 2026 (though Medtronic still owns roughly 90% of MiniMed shares, which will be relayed to its shareholders as a tax-free distribution in the foreseeable future). MiniMed is the leader in traditional, tubed insulin pumps and also offers continuous glucose monitors, smart insulin pens, and other consumables.
Minimed Group trades on the NASDAQ stock market under the symbol MMED.
As of October 6, 2026, MMED stock price declined to $19.75 with 3,055,476 million shares trading.
MMED has a beta of 0.29, meaning it tends to be less sensitive to market movements. MMED has a correlation of 0.00 to the broad based SPY ETF.
MMED has a market cap of $5.56 billion. This is considered a Mid Cap stock.
Last quarter Minimed Group reported $843 million in Revenue and $.00 earnings per share. This beat revenue expectation by $15 million and missed earnings estimates by -$.09.
The top ETF exchange traded funds that MMED belongs to (by Net Assets): FPX, IWM, VXF, IWN, VTWO.
MMED support price is $19.58 and resistance is $20.74 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MMED shares will trade within this expected range on the day.
